Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease. Buchheit KM, Laidlaw TM, Levy JM. J Allergy Clin Immunol 2021;148:348-350.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buchheit KM, Laidlaw TM, Levy JM. Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2021;148:348-350.
PMID: 34174296